Global Next Generation Sequencing Market Report and Forecast 2023-2031

The global next generation sequencing market size reached a value of USD 9.1 billion in 2022. The market is anticipated to grow at a CAGR of 13.8% during the forecast period of 2023-2031, reaching a value of USD 29.20 billion by 2031. The growth can be attributed to the increased demand for precision medicine, advancements in sequencing technologies, and the growing application of next generation sequencing in various fields.

Global Next Generation Sequencing Market: Introduction

The global next generation sequencing market is experiencing significant growth due to factors such as technological advancements, rising demand for personalized medicine, decreasing sequencing costs, increasing government funding, and the growing application of next generation sequencing in fields like oncology, clinical diagnostics, agriculture, and forensics. Key trends in the market include the rise of single-cell sequencing, growing adoption of cloud-based solutions, and the increasing use of artificial intelligence and machine learning in data analysis. These drivers have collectively contributed to the rapid expansion of next generation sequencing technologies, transforming genomic research and enabling more accurate and efficient identification of genetic mutations, disease risk assessment, and personalized treatment plans.

Applications and Uses

Next-generation sequencing has various applications, including whole-genome sequencing, targeted resequencing, transcriptomics, metagenomics, epigenomics, and gene expression profiling. These applications enable researchers and clinicians to study genetic variation, gene expression, and epigenetic changes, contributing to a better understanding of diseases and the development of personalized therapies. The growing adoption of next-generation sequencing in clinical diagnostics, drug discovery, and precision medicine is expected to further drive the growth of the market, leading to more innovative applications and a broader impact on global healthcare.

Next Generation Sequencing Market Segmentations

The market can be categorized into types, consumables, applications, end user, and major regions:

Market Breakup by Type

DNA Sequencing

• Whole Genome Sequencing
• Targeted Sequencing
• Whole Exome Sequencing
• Hybridization Capture
• Amplicon Sequencing
• Molecular Inversion Probes (MIPs)

RNA Sequencing

• Whole Transcriptome Sequencing (WTS)
• Targeted Gene Expression with RNA sequencing
• Ribosomal RNA Depletion

Epigenomics

• ChIP-Sequencing
• Methyl-Sequencing

Market Breakup by Consumables

Sample Preparation

• DNA Fragmentation
• End Repair
• A-Tailing
• Size Selection
• Library Preparation
• Target Enrichment
• Quality Control

Other Consumables

• Platforms
• HiSeq
• MiSeq
• Ion Torrent
• SOLiD
• Pacbio Rs II and Sequel System
• Other Platforms

Market Breakup by Applications

• Drug Discovery and Development
• Biomarker Discovery
• Biopharmaceutical Development
• Vaccine Development
• Pharmacogenomics
• Poly pharmacology

- Pharmacoepidemiology

Market Breakup by End User

• Clinical Research
• Academic Research
• Pharmaceutical and Biotechnology Companies
• Hospitals
• Others

Market Breakup by Region

North America

• United States of America
• Canada

Europe

• United Kingdom
• Germany
• France
• Italy
• Others

Asia Pacific

• China
• Japan
• India
• ASEAN
• Australia
• Others

Latin America

• Brazil
• Argentina
• Mexico
• Others

Middle East and Africa

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Next Generation Sequencing Market Analysis

The global next generation sequencing market has experienced significant growth in recent years, and this trend is expected to continue in the coming years Factors such as technological advancements, decreasing sequencing costs, increasing demand for personalized medicine, and growing application of next generation sequencing in various fields have contributed to the rapid expansion of the market.

North America, particularly the United States, holds the largest share of the global next generation sequencing market due to factors such as the presence of major market players, advanced healthcare infrastructure, and significant government funding. Europe and the Asia-Pacific regions are also expected to experience significant growth in the next generation sequencing market, driven by increasing research and development activities, growing healthcare expenditures, and rising demand for advanced diagnostic tools.

The global next generation sequencing market presents vast opportunities for growth and innovation, and it is expected to play a critical role in shaping the future of healthcare by enabling more accurate and efficient genomic research, disease risk assessment, and personalized treatment plans.

Key Players in the Global Next Generation Sequencing Market

The report gives an in-depth analysis of the key players involved in the next generation sequencing market, including manufacturers of sequencing instruments, reagents, and services. The companies included in the market are as follows:

• Illumina Inc
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific, Inc
• Bio-Rad Laboratories, Inc
• PierianDX
• Genomatrix GmbH
• DNASTAR, Inc
• Perkin Elmer, Inc,
• Eurofins GATC Biotech GmbH
• Agilent Technologies, Inc
• Danaher Corp
• BGI Genomics